View in EDS HTML Full Text PDF Full Text

COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial.

Saved in:
Bibliographic Details
Title: COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial.
Authors: Le, Michelle1 (AUTHOR) elena.netchiporouk@mcgill.ca, Khoury, Lauren2 (AUTHOR), Lu, Yang3 (AUTHOR), Prosty, Connor2 (AUTHOR), Cormier, Maxime4 (AUTHOR), Cheng, Mathew P5 (AUTHOR), Fowler, Robert6 (AUTHOR), Murthy, Srinivas7 (AUTHOR), Tsang, Jennifer L Y8 (AUTHOR), Ben-Shoshan, Moshe9 (AUTHOR), Rahme, Elham3 (AUTHOR), Golchi, Shirin3 (AUTHOR), Dendukuri, Nandini3 (AUTHOR), Lee, Todd C5 (AUTHOR), Netchiporouk, Elena1 (AUTHOR) elena.netchiporouk@mcgill.ca
Source: Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofae102